Johnson & Johnson appeals against $2bn talc ruling rejected by Supreme Court
  • X
  • LinkedIn
  • Show more sharing options
  • Print
  • X
  • LinkedIn
  • Free Trial
  • Log in

Johnson & Johnson appeals against $2bn talc ruling rejected by Supreme Court

Bernard Goyder
June 01, 2021
  • X
  • LinkedIn
  • Show more sharing options
  • Print
  • X
  • LinkedIn
Talcum powder medical stethecope doctor.jpg

The US Supreme Court has rejected an appeal by Johnson & Johnson over a lower court’s award of $2bn to a group of women who claim to have suffered ovarian cancer as a result of their exposure to talcum powder products.

A jury in Missouri originally awarded the women $4.7bn in compensation and damages in 2018, an award later reduced to $2bn by a state appeals court.

The

Subscribers, log in here:

Fuel a smarter strategy with our actionable market intelligence

      • Gain a competitive edge and accelerate decision-making
      • Be empowered by insights that transform confusion to clarity
      • Uncover growth opportunities and prepare for potential threats
      • Fuel a smarter strategy for business growth
Request a free trial Already a subscriber? Log in now

Topics

News Legal Casualty/GL
BG
Bernard Goyder
Gift this article